Oncology Trends
47 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Megan Campbell Smith
Scoop.it!

Roche's breast cancer franchise boosted by trial data

Roche reveals clinical trial data showing Herceptin helps breast cancer patients live longer.

more...
No comment yet.
Scooped by Megan Campbell Smith
Scoop.it!

Genomes-R-Us: Is BGI now Complete? | Xconomy

Genomes-R-Us: Is BGI now Complete? | Xconomy | Oncology Trends | Scoop.it

CBT Advisors' Steve Dickman investigates the failure of a US genomics corporation to find enough customers. Selling a complete human genome sequence for $4200, Complete Genomics ends up selling to their biggest competitor, China-based BGI. 

more...
No comment yet.
Scooped by Megan Campbell Smith
Scoop.it!

MIT team proposes $30B cancer research 'megafund' - Mass High Tech Business News

MIT team proposes $30B cancer research 'megafund' - Mass High Tech Business News | Oncology Trends | Scoop.it

Andrew Lo with MIT Sloan School of Management proposes crowdfunding plan to raise $30B in cancer research funds from diverse and private investors.

more...
No comment yet.
Scooped by Megan Campbell Smith
Scoop.it!

Foundation Medicine Grabs $42.5M For Cancer Genome Test | Xconomy

Foundation Medicine Grabs $42.5M For Cancer Genome Test | Xconomy | Oncology Trends | Scoop.it

Casting a wider net may bring more efficacy, and profits, to molecular abnormality screening. Foundation Medicine CEO Mike Pellini explains that of the $5800 test's 400 physician customers, 75% are repeat customers, making the firm attractive to investors.

more...
No comment yet.
Scooped by Megan Campbell Smith
Scoop.it!

Bayer's Stivarga Helps Colorectal Cancer Patients Live Longer - Businessweek

Bayer expects to earn $500M a year on Stivarga (regorafenib), the latest treatment option for colorectal cancer.

more...
No comment yet.